Stay updated on Azacitidine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine + Pembrolizumab in AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A general NIH notice about using “Super Intelligence” instead of “Artificial Intelligence” appears on the page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:00:05.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:14:27.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with standard site chrome, replacing the usual study record content. This indicates that access to the page is blocked.
    Difference
    20%
    Check dated 2026-09-23T00:29:05.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0, signaling a site update. The visible study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-09-16T00:10:35.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating an updated page version and likely related internal improvements or bug fixes.
    Difference
    0.1%
    Check dated 2026-09-01T19:15:01.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a newer version of the page. This update is a metadata increment and does not change visible content.
    Difference
    0.1%
    Check dated 2026-08-11T19:15:59.000Z thumbnail image

Stay in the know with updates to Azacitidine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine + Pembrolizumab in AML Clinical Trial page.